Home Tag "Rigel Pharmaceuticals"

Hot Movers: CBOE Holdings, Inc (NASDAQ:CBOE), Gol Linhas Aereas Inteligentes SA (ADR) (NYSE:GOL), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

CBOE Holdings, Inc (NASDAQ:CBOE) shares dropped 4.13% and closed at $48.74. The company on August 2 reported second quarter 2013 net income allocated to common stockholders of $45.5 million, or $0.52 per diluted share, compared with $37.9 million, or $0.44 per diluted share in the second quarter of 2012.  Adjusted net income allocated to common stockholders […]

Investors Buzz: Renren Inc(NYSE:RENN), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), ImmunoCellular Therapeutics Ltd (NYSEAMEX:IMUC), Magnum Hunter Resources Corp (NYSE:MHR)

Traders Alert: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), MedAssets, Inc. (NASDAQ:MDAS), NXP Semiconductors NV (NASDAQ:NXPI), Visa Inc (NYSE:V)

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares jumped 2.72% to $4.15. RIGL and AstraZeneca AB (AZ) on June 4 announced the topline results from OSKIRA-2 and OSKIRA-3, the remaining pivotal Phase 3 clinical trials investigating fostamatinib, the first oral spleen tyrosine kinase (SYK) inhibitor in development for rheumatoid arthritis (RA). MedAssets, Inc. (NASDAQ:MDAS) shares gained 2.72% to $23.40. The […]

The Ferrari Roma Explained